Lorianne Masuoka

Lorianne Masuoka

Geen lopende functies
64 jaar
Health Technology
Consumer Services

Profiel

Lorianne K.
Masuoka
worked as Senior Associate Director-Clinical Development at Bayer Schering Pharma AG and Berlex Laboratories, Inc. from 1994 to 2000.
From 2000 to 2003, served as Oncology Director at Chiron Corp.
Held the position of Vice President-Clinical Development at Five Prime Therapeutics, Inc. between 2003 and 2008.
Occupied the role of Chief Medical Officer & Senior Vice President at Nektar Therapeutics from 2009 to 2011.
Served as Chief Medical Officer at Cubist Pharmaceuticals LLC from 2013 to 2015, Invivo Therapeutics Holdings Corp.
from 2015 to 2017, Immedica Pharma US, Inc. from 2017 to 2019, Epygenix Therapeutics, Inc. from 2022 to 2023, and DiaMedica Therapeutics, Inc. from 2024 to 2025.
Held Independent Director roles at The Pelican, Inc. from 2019 to 2020 and Opiant Pharmaceuticals, Inc. from 2021 to 2023.
Education includes undergraduate and doctorate degrees from the University of California, Davis.

Eerdere bekende functies van Lorianne Masuoka

BedrijvenFunctieEinde
DIAMEDICA THERAPEUTICS INC. Hoofd Techniek/Wetenschap/O&O 04-08-2025
Hoofd Techniek/Wetenschap/O&O 01-12-2023
OPIANT PHARMACEUTICALS, INC. Directeur/Bestuurslid 02-03-2023
PFENEX INC. Directeur/Bestuurslid 01-10-2020
MARINUS PHARMACEUTICALS, INC. Hoofd Techniek/Wetenschap/O&O 31-10-2019
Ervaring van Lorianne Masuoka in detail bekijken

Opleiding van Lorianne Masuoka

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

55

Eerstegraads connecties

13

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Berlex Laboratories, Inc.

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Lorianne Masuoka
40 % korting: de beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU